Patents by Inventor Donald Andrew Cameron

Donald Andrew Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for inhibiting CYP26 enzymes
    Patent number: 11795148
    Abstract: Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 24, 2023
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Uttam Saha
  • Compounds and methods for inhibiting CPY26 enzymes
    Patent number: 11364220
    Abstract: Compounds described herein are inhibitors of retinoic add inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: June 21, 2022
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Toni Kristian Rantanen, Victor Snieckus, Johnathan Board, Suneel Singh, Ashishkumar Jayantilal Maheta
  • Compounds and methods for inhibiting CYP26 enzymes
    Patent number: 11358933
    Abstract: Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: June 14, 2022
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Uttam Saha
  • Compounds and Methods for Inhibiting CPY26 Enzymes
    Publication number: 20210220326
    Abstract: Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
    Type: Application
    Filed: November 26, 2020
    Publication date: July 22, 2021
    Inventors: Donald Andrew Cameron, Martin Petkovich, Toni Kristian Rantanen, Victor Snieckus, Johnathan Board, Suneel Singh, Ashishkumar Jayantilal Maheta
  • Compounds and Methods for Inhibiting CYP26 Enzymes
    Publication number: 20210107870
    Abstract: Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids.
    Type: Application
    Filed: October 29, 2020
    Publication date: April 15, 2021
    Inventors: Donald Andrew Cameron, Martin Petkovich, Uttam Saha
  • Compounds and methods for inhibiting CYP26 enzymes
    Patent number: 10874634
    Abstract: Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: December 29, 2020
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Toni Kristian Rantanen, Victor Snieckus, Johnathan Board, Suneel Singh, Ashishkumar Jayantilal Maheta
  • Compounds and Methods for Inhibiting CYP26 Enzymes
    Publication number: 20200369609
    Abstract: Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids.
    Type: Application
    Filed: December 12, 2018
    Publication date: November 26, 2020
    Inventors: Donald Andrew Cameron, Martin Petkovich, Uttam Saha
  • Compounds and Methods for Inhibiting CPY26 Enzymes
    Publication number: 20200093788
    Abstract: Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 26, 2020
    Inventors: Donald Andrew Cameron, Martin Petkovich, Toni Kristian Petkovich, Victor Snieckus, Johnathan Board, Suneel Singh, Ashishkumar Jayantilal Maheta